A study of whether embryonic stem cells could cure spinal-cord injury suffered from high costs, dim prospects.
Antonio RegaladoFollow @twitterapi
Senior Editor, Business
I am the business editor of MIT Technology Review. I look for stories about how technology is changing business. Before joining MIT Technology Review in July 2011, I lived in São Paulo, Brazil, where I wrote about science, technology, and politics in Latin America for Science and other publications. From 2000 to 2009, I was the science reporter at the Wall Street Journal and later a foreign correspondent.
Antonio Regalado's Stories
The lead designer of the Android user interface has the job of making Google's mobile operating system desirable to consumers.
Now that every technology company in America seems to be selling cloud computing, we decided to find out where it all began.
Cloud computing is changing how businesses, consumers, and even armies store and use data. Technology Review looks at six ideas at the cutting edge.
How a brush with death turned an unknown tech marketer into a champion of electronic medicine.
A company set up to handle prescription orders could be the key to the health-care Internet.
An innovator delivers a cheap, instant, and mobile way to monitor heart problems.
Learn the secrets of working with Apple on iPhone gear.
A look, in numbers, at the forces shaping electronic medicine.
A small biotech firm is the second company to start human tests of embryonic stem-cell therapy.